跳至主要内容
临床试验/NCT01605461
NCT01605461已完成1 期

Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
1
主要终点
AUC0-infinity of Plasma Deleobuvir

研究概览

简要总结

Phase 1 study to assess the pharmacokinetics and routes of elimination of a single oral dose of [14C]-BI 207127 and to characterize the metabolic profile following single dose administration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

BI 207127 NA

Experimental

Single oral solution dose of BI 207127 NA combined with [14C]-BI 207127 NA

干预措施: BI 207127 NA (Drug)

结局指标

主要结局

AUC0-infinity of Plasma Deleobuvir

时间窗: 15 minutes (min) before drug administration and 30min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 3h 30min, 4h, 5h, 6h, 8h, 10h, 12h, 15h, 24h, 36h, 48h, 72h and 96h after drug administration

Area under the plasma deleobuvir concentration-time curve over the time interval from 0 h extrapolated to infinity (AUC0-infinity)

Cmax of Plasma Deleobuvir

时间窗: 15 minutes (min) before drug administration and 30min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 3h 30min, 4h, 5h, 6h, 8h, 10h, 12h, 15h, 24h, 36h, 48h, 72h and 96h after drug administration

Maximum measured concentration (Cmax) of plasma deleobuvir

Excretion Balance of Total [14C]-Radioactivity

时间窗: Before drug administration (24hours (h) to 15 minutes pre-dose) and 0h-24h, 24h-48h, 48h-72h, 72h-96h, 96h-120h, 120h-144h, 144h-168h, 168h-192h and 192h-216h after drug administration

Excretion balance of total \[14C\]-radioactivity (urine and faeces)

t1/2 of [14C]-Radioactivity in Plasma

时间窗: 15 minutes (min) before drug administration and 30min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 3h 30min, 4h, 5h, 6h, 8h, 10h, 12h, 15h, 24h, 36h, 48h, 72h and 96h after drug administration

Terminal half life (T1/2) of \[14C\]-radioactivity in plasma

Excretion of Total [14C]-Radioactivity in Urine

时间窗: Before drug administration (24hours (h) to 15 minutes pre-dose) and 0h-24h, 24h-48h, 48h-72h, 72h-96h, 96h-120h, 120h-144h, 144h-168h, 168h-192h and 192h-216h after drug administration

Excretion of total \[14C\]-radioactivity in urine

Excretion of Total [14C]-Radioactivity in Faeces

时间窗: Before drug administration (24hours (h) to 15 minutes pre-dose) and 0h-24h, 24h-48h, 48h-72h, 72h-96h, 96h-120h, 120h-144h, 144h-168h, 168h-192h and 192h-216h after drug administration

Excretion of total \[14C\]-radioactivity in faeces

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验